V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004010 | 300002809 | 1.56 | 96 | Curative (C) | 2015-05-29 | 2015-06-10 | CETUXIMAB + RT | N | Y | 300017627 | CETUXIMAB + RT |
| 300004012 | 300002811 | 1.63 | 65.4 | Palliative (P) | 2014-01-28 | 2014-02-15 | Trial Unspecified | N | N | 300017637 | TRIAL |
| 300004013 | 300002812 | 1.84 | 104.6 | null | 2017-06-14 | 2017-06-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017639 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004014 | 300002813 | 1.56 | null | null | 2017-03-17 | 2017-04-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017642 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004015 | 300002814 | 1.52 | 88 | Neo-adjuvant (N) | 2015-07-21 | 2015-07-28 | CISPLATIN + FLUOROURACIL | 02 | N | 300017644 | CISPLATIN + FLUOROURACIL |
| 300004016 | 300002815 | 1.84 | 84 | Palliative (P) | 2014-11-25 | 2014-11-25 | Trial Unspecified | N | N | 300017646 | TRIAL |
| 300004017 | 300002815 | 1.8 | 108 | null | 2015-09-20 | 2015-09-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300017646 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004018 | 300002816 | 1.64 | 77 | Neo-adjuvant (N) | 2015-02-02 | 2015-02-02 | CISPLATIN + FLUOROURACIL | 02 | null | 300017655 | CISPLATIN + FLUOROURACIL |
| 300004019 | 300002817 | 1.57 | 64.75 | null | 2015-07-20 | 2015-07-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 300017657 | CISPLATIN + FLUOROURACIL |
| 300004020 | 300006046 | 1.85 | 44.25 | Palliative (P) | 2017-02-24 | 2016-08-29 | Cisplatin +Fluorouracil (3 wk) | N | N | 300017661 | CISPLATIN + FLUOROURACIL |
| 300004021 | 300002818 | 1.55 | 66.15 | null | 2016-09-11 | 2016-09-18 | CISPLATIN + FLUOROURACIL | N | N | 300017667 | CISPLATIN + FLUOROURACIL |
| 300004022 | 300002819 | 1.73 | 64.9 | Curative (C) | null | 2014-05-09 | Cetuximab 7 day (Cycle 1) | null | Y | 300017673 | CETUXIMAB |
| 300004023 | 300002820 | 1.79 | null | Neo-adjuvant (N) | 2017-10-25 | 2017-11-11 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017681 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004024 | 300002821 | 1.69 | 112 | Curative (C) | 2014-06-19 | 2014-06-21 | CETUXIMAB | N | Y | 300017685 | CETUXIMAB |
| 300004025 | 300006047 | null | null | Curative (C) | 2013-06-26 | 2013-06-27 | CETUXIMAB | 02 | Y | 300017689 | CETUXIMAB |
| 300004026 | 300006047 | 1.6 | 80.5 | Adjuvant (A) | 2015-03-03 | 2015-05-05 | Capecitabine | N | N | 300017689 | CAPECITABINE |
| 300004027 | 300006047 | null | 77 | Neo-adjuvant (N) | 2015-07-21 | 2015-08-02 | Cisplatin +Fluorouracil (3 wk) | N | N | 300017689 | CISPLATIN + FLUOROURACIL |
| 300004028 | 300006047 | null | null | Palliative (P) | 2014-12-09 | 2014-12-29 | Trial Unspecified | N | N | 300017689 | TRIAL |
| 300004029 | 300002822 | 1.73 | 94.2 | Palliative (P) | 2018-07-01 | 2018-07-08 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300017704 | CARBOPLATIN + PACLITAXEL |
| 300004030 | 300002823 | null | 86.95 | null | null | 2016-09-03 | Cisplatin + Docetaxel +Fluorouracil | null | N | 300017707 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004031 | 300002823 | null | 70.6 | null | 2013-10-25 | 2013-11-13 | Trial Unspecified | Y | Y | 300017707 | TRIAL |
| 300004032 | 300002823 | 1.88 | 64.9 | Palliative (P) | null | 2016-09-11 | CARBOPLATIN + PACLITAXEL | null | Y | 300017707 | CARBOPLATIN + PACLITAXEL |
| 300004033 | 300002824 | 1.65 | 92.8 | Curative (C) | 2017-03-03 | 2017-03-23 | Cetuximab + Radiotherapy Load | null | Y | 300017717 | CETUXIMAB + RT |
| 300004034 | 300002825 | 1.43 | 93.7 | Curative (C) | 2013-04-23 | 2013-05-05 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017721 | CISPLATIN + FLUOROURACIL |
| 300004035 | 300006049 | 1.81 | 97.4 | null | 2015-11-16 | 2015-11-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300017727 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004036 | 300002826 | 1.78 | 79 | Palliative (P) | 2014-09-16 | 2014-09-19 | Cetuximab 7 day (Cycle 1) | N | null | 300017729 | CETUXIMAB |
| 300004037 | 300002827 | 1.8 | 70 | Curative (C) | 2016-08-30 | 2016-08-31 | CETUXIMAB + RT | Y | Y | 300017738 | CETUXIMAB + RT |
| 300004038 | 300002828 | 1.63 | 73.4 | Neo-adjuvant (N) | 2018-01-22 | 2018-01-22 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017740 | CISPLATIN + FLUOROURACIL |
| 300004039 | 300002829 | 1.78 | 71.3 | Palliative (P) | 2017-02-27 | 2017-02-28 | CISPLATIN + FLUOROURACIL | Y | null | 300017743 | CISPLATIN + FLUOROURACIL |
| 300004040 | 300002829 | 1.74 | 91 | Neo-adjuvant (N) | 2016-02-13 | 2016-02-17 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 300017743 | CISPLATIN + FLUOROURACIL |
| 300004041 | 300002830 | null | 78.7 | Palliative (P) | 2015-08-08 | 2015-08-26 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300017752 | CARBOPLATIN + PACLITAXEL |
| 300004043 | 300002832 | 1.64 | 97.2 | Neo-adjuvant (N) | null | 2015-08-01 | CISPLATIN + FLUOROURACIL | Y | null | 300017758 | CISPLATIN + FLUOROURACIL |
| 300004044 | 300002833 | null | 49.6 | Palliative (P) | 2016-10-08 | 2016-10-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017759 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004045 | 300002834 | null | 102 | Curative (C) | 2016-07-07 | 2016-07-22 | Cetuximab + Radiotherapy Load | null | Y | 300017768 | CETUXIMAB + RT |
| 300004046 | 300002834 | 1.63 | 51.3 | Neo-adjuvant (N) | 2014-04-19 | 2014-04-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017768 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004047 | 300007433 | 1.77 | 105 | Neo-adjuvant (N) | 2012-10-11 | 2014-07-19 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300017779 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004048 | 300007433 | null | 92.9 | Neo-adjuvant (N) | 2015-02-12 | 2015-02-16 | CISPLATIN + FLUOROURACIL | N | N | 300017779 | CISPLATIN + FLUOROURACIL |
| 300004049 | 300002835 | 1.78 | 48.1 | Curative (C) | 2013-04-06 | 2013-04-13 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300017783 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004050 | 300002836 | 1.52 | 122.2 | null | 2017-11-10 | 2017-11-23 | CISPLATIN + FLUOROURACIL | 02 | N | 300017795 | CISPLATIN + FLUOROURACIL |
| 300004052 | 300002838 | 1.6 | 102.7 | Palliative (P) | 2015-12-07 | 2015-12-07 | CISPLATIN + FLUOROURACIL | 2 | N | 300017803 | CISPLATIN + FLUOROURACIL |
| 300004053 | 300002838 | 1.62 | 61.8 | Neo-adjuvant (N) | 2016-07-29 | 2016-08-12 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300017803 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004054 | 300002839 | null | null | Adjuvant (A) | 2016-04-27 | 2016-05-11 | CETUXIMAB + RT | null | Y | 300017811 | CETUXIMAB + RT |
| 300004055 | 300002840 | null | 66.2 | Curative (C) | null | 2014-11-14 | CISPLATIN + FLUOROURACIL | null | null | 300017813 | CISPLATIN + FLUOROURACIL |
| 300004056 | 300002841 | 1.65 | 77.4 | Not known (9) | 2013-08-07 | 2013-08-08 | Carboplatin + Paclitaxel (weekly) | 02 | null | 300017815 | CARBOPLATIN + PACLITAXEL |
| 300004057 | 300002841 | 1.65 | 66.7 | Neo-adjuvant (N) | 2016-08-07 | 2017-11-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017815 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004058 | 300002842 | 1.77 | 60.3 | Curative (C) | 2015-12-22 | 2016-01-06 | CETUXIMAB + RT | N | Y | 300017819 | CETUXIMAB + RT |
| 300004059 | 300002843 | 1.53 | 98 | Curative (C) | null | 2016-02-16 | Trial Unspecified | Y | N | 300017821 | TRIAL |
| 300004060 | 300002844 | 1.73 | 66.7 | Neo-adjuvant (N) | 2016-11-27 | 2016-12-02 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300017826 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004061 | 300002845 | 1.6 | 92.9 | Neo-adjuvant (N) | 2015-09-08 | 2015-08-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017829 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004062 | 300002846 | 1.8 | 64.5 | Curative (C) | 2015-12-15 | 2016-01-21 | Trial Unspecified | N | Y | 300017832 | TRIAL |